Glaukos Announces Submission of Supplemental Pre-Market Approval Application for iStent infinite™
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the...